Robert Van Nostrand, CPA
Mr. Van Nostrand is the Chairman of Finance and Audit at LikeMinds.
Robert is a seasoned leader in the biotech and pharmaceutical
industries, bringing more than 30 years of experience in the private
sector to become a valuable industry resource through board participation and
industry leadership positions. For 21 years Mr. Van Nostrand was at OSI
Pharmaceuticals, Inc., or OSI, a biotechnology company, serving in a variety of
executive positions including Chief Financial Officer as well as SVP and Chief
Compliance Officer. After this, Mr. Van Nostrand was EVP and Chief Financial Officer
of Aureon Laboratories, Inc., a pathology life science company. Prior to that, Mr. Van
Nostrand served as EVP and Chief Financial Officer of AGI Dermatics, a private
biotechnology company, from July 2007 to September 2008 when the company was
acquired. Today, Mr. Van Nostrand serves as a director of several biotech and related
companies. He is currently on the Board of Directors of Achillion Pharmaceuticals and
Enumeral Biomedical Corporation, both biotechnology companies, Intra-Cellular
Therapies, a biopharmaceutical company, Yield10 Bioscience, Inc., formerly Metabolix,
Inc., a bio agricultural company, and the Biomedical Research Alliance of New York,
a private company providing clinical trial services. Mr. Van Nostrand holds a B.S. in
Accounting from Long Island University, New York and completed advanced
management studies at the Wharton School of the University of Pennsylvania.